HDAC9 and neoplasm: Indeed, HDAC inhibitors have been employed in cancer therapy based on the fact that inhibition of these enzyme activities—which were largely elevated in several tumor types [35]—can modulate the deviant chromatin structure and the abnormal cytosolic protein functions of the tumors [36,37].